Targeting Alzheimer amyloid plaques in vivo (original) (raw)

References

  1. Maggio, J.E. & Mantyh, P.W. Brain amyloid—a physicochemical perspective. Brain Pathol. 6, 147–162 (1996).
    Article CAS Google Scholar
  2. Manelli, A.M. & Puttfarcken, P.S. Beta-amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals. Brain Res. Bull. 38, 569–576 (1995).
    Article CAS Google Scholar
  3. Weldon, D.T. et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161–2173 (1998).
    Article CAS Google Scholar
  4. Selkoe, D.J. Alzheimer's disease: genotypes, phenotype, and treatments. Science 275, 630–631 (1997).
    Article CAS Google Scholar
  5. Hsiao, K. et al. Correlative memory deficits, A-beta elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
    Article CAS Google Scholar
  6. Holcomb, L. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97–100 (1998).
    Article CAS Google Scholar
  7. Cummings, B.J. & Cotman, C.W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346, 1524–1528 (1995).
    Article CAS Google Scholar
  8. Maggio, J.E. et al. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89, 5462–5466 (1992).
    Article CAS Google Scholar
  9. Ghilardi, J.R. et al. Intra-arterial infusion of [I-125]A-beta 1-40 labels amyloid deposits in the aged primate brain in vivo. NeuroReport 7, 2607–2611 (1996).
    Article CAS Google Scholar
  10. Poduslo, J.F. & Curran, G.L. Increased permeability across the blood–nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. Proc. Natl. Acad. Sci.USA 89, 2218–2222 (1992).
    Article CAS Google Scholar
  11. Poduslo, J.F. & Curran, G.L. Glycation increases in permeability of proteins across the blood–nerve and blood–brain barriers. Molec. Brain Res. 23, 157–162 (1994).
    Article CAS Google Scholar
  12. Poduslo, J.F., Curran, G.L. & Berg, C.T. Macromolecular permeability across the blood–nerve and blood–brain barriers. Proc. Natl. Acad. Sci.USA 9, 5705–5709 (1994).
    Article Google Scholar
  13. Poduslo, J.F. & Curran, G.L. Polyamine modification increases the permeability of proteins at the blood–nerve and blood–brain barriers. J. Neurochem. 66, 1599–1609 (1996).
    Article CAS Google Scholar
  14. Poduslo, J.F. & Curran, G.L. Increased permeability of superoxide dismutase at the blood–nerve and blood–brain barriers with retained enzymatic activity after covalent modification with the naturally occurring polyamine, putrescine. J. Neurochem. 67, 734–741 (1996).
    Article CAS Google Scholar
  15. Wengenack, T.M., Curran, G.L., Olson, E.E. & Poduslo, J.F. Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood–nerve and blood–brain barriers. Brain Res. 767, 128–135 (1997).
    Article CAS Google Scholar
  16. Poduslo, J.F., Curran, G.L. & Gill, J.S. Putrescine-modified NGF: bioactivity, pharmacokinetics, blood–brain/nerve barrier permeability, and nervous system biodistribution. J. Neurochem. 71, 1651–1660 (1998).
    Article CAS Google Scholar
  17. Poduslo, J.F., Curran, G.L., Haggard, J.J., Biere, A.L. & Selkoe, D.J. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid β-protein 1-40 at the blood–brain barrier. Neurobiol. Dis. 4, 27–34 (1997).
    Article CAS Google Scholar
  18. Poduslo, J.F., Curran, G.L., Sanyal, B. & Selkoe, D.J. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood–brain barrier. Neurobiol Dis. 6, 190–199 (1999).
    Article CAS Google Scholar
  19. Walker, L.C., Masters, C., Beyreuther, K. & Price, D.L. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol. 80, 381–387 (1990).
    Article CAS Google Scholar
  20. Vinters, H.V. & Pardridge, W.M. The blood–brain barrier in Alzheimer's disease. Can. J. Neurol. Sci. 13, 446–448 (1986).
    Article CAS Google Scholar
  21. Soto, C., Kindy, M.S., Baumann, M. & Frangione, B. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem. Biophys. Res. Commun. 226, 672–680 (1996).
    Article CAS Google Scholar
  22. Poduslo, J.F., Curran, G.L., Kumar, A., Frangione, B. & Soto, C. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood–brain barrier permeability and resistance to proteolytic degradation in plasma. J. Neurobiol. 39, 371–382 (1999).
    Article CAS Google Scholar
  23. Abbott, N.J., Chugani, D.C., Zaharchuk, G., Rosen, B.R. & Lo, E.H. Delivery of imaging agents into brain. Advances Drug Delivery Rev. 37, 253–277 (1999).
    Article CAS Google Scholar

Download references